Physician profile
Timothy L Stone
NPI 1932175437
$2,399.24
in general payments reported to CMS, 2019-2025
34 companies · $258 in 2025
The $258 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $435 · 2020: $343 · 2021: $385 · 2022: $283 · 2023: $394 · 2024: $301 · 2025: $258.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $953.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $953.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $455.46 | 2019-2024 | Liletta, Lo Loestrin Fe, Orilissa |
| Astellas Pharma US INC | $410.68 | 2019-2024 | Veozah, Myrbetriq |
| Shield Therapeutics INC | $200.65 | 2022-2025 | Accrufer |
| Therapeuticsmd, INC. | $127.32 | 2019-2022 | |
| Ethicon US, LLC | $121.09 | 2019-2025 | Surgicel Nu-Knit, Stratafix, Evarrest |
| Hologic Sales and Service, LLC | $107.38 | 2020-2025 | Aptima |
| Amgen INC. | $102.96 | 2019-2025 | Evenity |
| Mylan Pharmaceuticals INC. | $74.95 | 2019-2022 | |
| Coopersurgical, INC. | $67.53 | 2020-2021 | |
| Lilly USA, LLC | $66.90 | 2020-2025 | Zepbound |
| Scynexis, INC. | $63.51 | 2022 | |
| Virtus Pharmaceuticals LLC | $49.20 | 2021 | |
| Aspira Women'S Health INC | $44.99 | 2021 | |
| Exeltis, USA INC. | $42.29 | 2020-2023 | Slynd |
| Minerva Surgical, INC | $41.22 | 2023-2024 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $37.26 | 2023 | Axonics |
| Bayer Healthcare Pharmaceuticals INC. | $37.21 | 2020-2025 | |
| Convatec INC. | $32.95 | 2019 | |
| Novo Nordisk INC | $28.79 | 2019-2021 | |
| Duchesnay USA Incorporated | $28.20 | 2019-2020 | |
| Vertical Pharmaceuticals, LLC | $27.75 | 2019-2020 | |
| Organon LLC | $27.70 | 2022-2023 | Jada System |
| Roche Diagnostics Corporation | $21.54 | 2019 | |
| Ibsa Pharma INC. | $21.48 | 2023 | Tirosint, Licart |
| Meditrina | $21.18 | 2025 | |
| Lundbeck LLC | $20.40 | 2021 | |
| Exact Sciences Corporation | $17.40 | 2024 | Cologuard Collection Kit |
| Sage Therapeutics, LLC | $16.89 | 2024 | |
| Amag Pharmaceuticals, INC. | $16.15 | 2019 | |
| Mayne Pharma Commercial LLC | $14.83 | 2025 | |
| Becton, Dickinson and Company | $14.55 | 2023 | Bd Onclarity |
| Lsi Solutions INC | $14.27 | 2021 | |
| Coloplast Corp | $12.56 | 2021 | |
| Lupin INC. | $12.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timothy Stone listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.